I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table2_Ethics of access to newly approved expensive medical..:
Charlotte H. C. Bomhof
;
Jilles Smids
;
Sybren Sybesma
..
doi:10.3389/fphar.2023.1265029.s002. , 2024
Link:
https://doi.org/10.3389/fphar.2023.1265029.s002
RT Journal T1
Table2_Ethics of access to newly approved expensive medical treatments: multi-stakeholder dialogues in a publicly funded healthcare system.DOCX
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_25100639&Exemplar=1&LAN=DE A1 Charlotte H. C. Bomhof A1 Jilles Smids A1 Sybren Sybesma A1 Maartje Schermer A1 Eline M. Bunnik YR 2024 K1 Pharmacology K1 Basic Pharmacology K1 Clinical Pharmacology and Therapeutics K1 Clinical Pharmacy and Pharmacy Practice K1 Pharmaceutical Sciences K1 Pharmacogenomics K1 Toxicology (incl. Clinical Toxicology) K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified K1 empirical bioethics K1 stakeholder engagement K1 access to expensive treatments K1 healthcare policy K1 ethics JF doi:10.3389/fphar.2023.1265029.s002 LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1265029.s002 DO https://doi.org/10.3389/fphar.2023.1265029.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)